Barnett & Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19M Sell
6,495
-40
-0.6% -$21.7K 2.48% 11
2025
Q4
$3.79M Hold
6,535
3.05% 8
2025
Q3
$3.17M Hold
6,535
2.45% 11
2025
Q2
$2.65M Hold
6,535
2.08% 12
2025
Q1
$3.25M Sell
6,535
-4,100
-39% -$2.22M 2.72% 9
2024
Q4
$5.53M Hold
10,635
3.62% 9
2024
Q3
$6.58M Sell
10,635
-318
-3% -$188K 4.35% 4
2024
Q2
$6.06M Hold
10,953
4.35% 4
2024
Q1
$6.37M Sell
10,953
-35
-0.3% -$19.6K 4.36% 4
2023
Q4
$5.83M Hold
10,988
4.37% 4
2023
Q3
$5.56M Hold
10,988
4.34% 3
2023
Q2
$5.73M Sell
10,988
-875
-7% -$472K 4.26% 3
2023
Q1
$6.84M Sell
11,863
-139
-1% -$78.3K 5.19% 1
2022
Q4
$6.61M Hold
12,002
5.05% 2
2022
Q3
$6.09M Sell
12,002
-500
-4% -$280K 5.38% 2
2022
Q2
$6.79M Sell
12,502
-74
-0.6% -$40.7K 5.43% 1
2022
Q1
$7.43M Sell
12,576
-359
-3% -$206K 5.27% 1
2021
Q4
$8.63M Sell
12,935
-320
-2% -$200K 6.02% 1
2021
Q3
$7.57M Sell
13,255
-2,058
-13% -$1.13M 5.7% 1
2021
Q2
$7.72M Sell
15,313
-735
-5% -$347K 5.11% 1
2021
Q1
$7.32M Sell
16,048
-660
-4% -$315K 3.9% 3
2020
Q4
$7.78M Sell
16,708
-267
-2% -$125K 4.89% 3
2020
Q3
$7.5M Sell
16,975
-55
-0.3% -$22.7K 5.35% 1
2020
Q2
$6.17M Sell
17,030
-1,214
-7% -$407K 5.01% 2
2020
Q1
$5.17M Sell
18,244
-900
-5% -$284K 4.98% 4
2019
Q4
$6.22M Sell
19,144
-2,386
-11% -$723K 3.78% 4
2019
Q3
$6.27M Buy
21,530
+4
+0% +$1.15K 3.67% 4
2019
Q2
$6.32M Sell
21,526
-240
-1% -$66.1K 3.56% 5
2019
Q1
$5.96M Sell
21,766
-20
-0.1% -$4.98K 3.4% 6
2018
Q4
$4.88M Sell
21,786
-1,620
-7% -$380K 2.79% 9
2018
Q3
$5.71M Hold
23,406
2.6% 9
2018
Q2
$4.85M Sell
23,406
-165
-0.7% -$35K 2.35% 10
2018
Q1
$4.87M Sell
23,571
-600
-2% -$126K 2.5% 7
2017
Q4
$4.59M Sell
24,171
-535
-2% -$102K 2.24% 9
2017
Q3
$4.67M Sell
24,706
-2,525
-9% -$457K 2.37% 7
2017
Q2
$4.75M Sell
27,231
-565
-2% -$94.9K 2.26% 4
2017
Q1
$4.27M Buy
27,796
+230
+0.8% +$35.2K 2.34% 4
2016
Q4
$3.89M Sell
27,566
-40
-0.1% -$5.9K 2.03% 8
2016
Q3
$4.39M Sell
27,606
-400
-1% -$61.6K 2.37% 4
2016
Q2
$4.14M Sell
28,006
-1,345
-5% -$199K 2.3% 5
2016
Q1
$4.16M Sell
29,351
-975
-3% -$131K 2.19% 6
2015
Q4
$4.3M Sell
30,326
-605
-2% -$80.7K 2.27% 6
2015
Q3
$3.78M Buy
30,931
+2,640
+9% +$344K 1.83% 10
2015
Q2
$3.67M Sell
28,291
-685
-2% -$89.3K 1.51% 17
2015
Q1
$3.89M Sell
28,976
-1,115
-4% -$144K 1.53% 18
2014
Q4
$3.77M Sell
30,091
-10
-0% -$1.22K 1.45% 21
2014
Q3
$3.66M Buy
30,101
+25
+0.1% +$3.04K 1.47% 15
2014
Q2
$3.55M Sell
30,076
-490
-2% -$57.7K 1.49% 15
2014
Q1
$3.67M Sell
30,566
-1,100
-3% -$131K 1.65% 10
2013
Q4
$3.53M Sell
31,666
-2,968
-9% -$295K 1.64% 13
2013
Q3
$3.19M Buy
34,634
+1,823
+6% +$165K 1.64% 13
2013
Q2
$2.78M Buy
+32,811
New +$2.73M 1.52% 15

Other funds holding TMO

Barnett & Company's TMO Position: Q1 2026 in Review

Barnett & Company reduced its Thermo Fisher Scientific (TMO) stake by 0.61% in Q1 2026, selling an estimated $21.7K and leaving 6,495 shares worth $3.19M. The position accounts for 2.48% of the portfolio, ranked #11.

Barnett & Company first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.63M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Barnett & Company held 6,495 shares of Thermo Fisher Scientific worth $3.19M as of Q1 2026.
  • Barnett & Company sold 40 Thermo Fisher Scientific shares in Q1 2026, an estimated $21.7K.
  • Thermo Fisher Scientific made up 2.48% of Barnett & Company's portfolio in Q1 2026, its #11 holding.
  • Barnett & Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Barnett & Company's Thermo Fisher Scientific position peaked at $8.63M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Barnett & Company's 13F filing for Q1 2026, filed 30 Apr 2026.